Please provide your email address to receive an email when new articles are posted on . Ovaprene, a monthly hormone-free contraceptive, blocked motile sperm in an early-phase study. There were no ...

Please provide your email address to receive an email when new articles are posted on . Levonorgestrel-releasing intrauterine system users vs. nonusers had an increased risk for breast cancer. Breast ...

A new at-home spit test appears to be as effective as birth control pills at preventing pregnancy – and it will soon roll out across Europe, Euronews Health has learned. The device from Inne, a Berlin ...

Why should women in British Columbia, Manitoba, Prince Edward Island and the Yukon have access to free contraception while the rest of Canadians do not? Our new research, published in the British ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Venova Technologies, Inc., a women-led startup developing a novel long-acting, hormone-free and copper-free female birth control device, has been awarded a $2.23M ...

Many women have used some form of contraceptive over the course of their childbearing years. Recently, the number of birth control methods available has grown significantly. The methods include new ...

(Reuters) - The U.S. Food and Drug Administration said it would discuss the safety and effectiveness of Bayer AG's controversial contraceptive device, Essure, in a public panel meeting after receiving ...

(Reuters) - The U.S. Food and Drug Administration approved a hormonal contraceptive device on Friday that gives American women another reversible contraceptive choice as effective as sterilization.

Since it was approved to go on the market in 2002, Essure, an implantable permanent contraceptive device, has been plagued by controversy. Thousands of women have filed grievances with the US Food and ...

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...